weight loss surgery vs glp-1 agonists bariatric comparison Metabolic and versus glucagon-like peptide-1 receptor agonist therapy: A of cardiovascular outcomes in patients with obesity Bariatric Surgery Yields 5x More – Bariatric Surgery Vs. GLP-1: Which

Macdonald-Clarke CJ, Martin BR, McCabe LD, McCabe GP, Lachcik PJ, Wastney M, et al

Orforglipron, made by the same company that produces the GLP-1 medications Zepbound and Mounjaro (tirzepatide), is an oral medication undergoing FDA clinical tests for use in weight loss

When your glucose is constantly spiking and outside of a healthy range, there can be negative impacts on your health ranging from inflammation, to cell damage, disease risk and weight gain

The patch typically contains the active GLP-1 analogue within a reservoir or matrix system, alongside penetration enhancers that facilitate drug passage through the stratum corneum (the skin's outer protective layer)